Market research
019175.KO Shin Poong Pharm.Co.,Ltd
KO KRW Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 682B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.14
Profile
Instrument facts
- Exchange
- KO
- Currency
- KRW
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- KR7019171008
- Market cap
- 682B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.14
About
About Shin Poong Pharm.Co.,Ltd
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.
Research context
Shin Poong Pharm.Co.,Ltd appears in PyInvesting’s Korea Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- KRW
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 019175.KO discussion.
5 years, 6 months ago
Shin Poong Pharm.Co.,Ltd is currently in a long term downtrend where the price is trading 21.8% below its 200 day moving average.
From a valuation standpoint, the stock is 146.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 21.1.
Shin Poong Pharm.Co.,Ltd's total revenue rose by 1.8% to $49B since the same quarter in the previous year.
Its net income has dropped by 57.2% to $480M since the same quarter in the previous year.
Finally, its free cash flow grew by 81.4% to $4B since the same quarter in the previous year.
Based on the above factors, Shin Poong Pharm.Co.,Ltd gets an overall score of 2/5.